Insiders · SGRP

John B Bode

Director at SPAR Group, Inc. (SGRP) since October 2023

John B Bode has filed 14 insider reports with the SEC since May 2023, as director at SPAR Group, Inc. (SGRP), director at Zevra Therapeutics, Inc. (ZVRA) and director at Newton Golf Company, Inc. (NWTG). John B Bode made no open-market purchases or sales in the last 12 months. The latest filing, on October 2, 2026, reports grant or award at SPAR Group, Inc. (SGRP).

Filings
14
Companies
3
Bought on market
$286K
Sold on market
None

Companies where John B Bode is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
SPAR Group, Inc. logo
SGRP
SPAR Group, Inc.
Directorsince October 2023110,000$0.2875Oct 2, 2026
Zevra Therapeutics, Inc. logo
ZVRA
Zevra Therapeutics, Inc.
Directorsince April 2023123,400$286K$6.35$9.40+48%Mar 26, 2026
Newton Golf Company, Inc. logo
NWTG
Newton Golf Company, Inc.
Directorsince January 202618,549$0.7072Feb 4, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare John B Bode with

Other insiders at the same companies

Questions about John B Bode

What is John B Bode's role at SPAR Group, Inc.?
John B Bode reports to the SEC as director at SPAR Group, Inc. (SGRP), according to the latest filing on October 2, 2026. John B Bode has also filed as director at Zevra Therapeutics, Inc. (ZVRA) and director at Newton Golf Company, Inc. (NWTG).
How many shares does John B Bode own?
After the latest filing that states it, John B Bode directly owned 110,000 shares of SPAR Group, Inc. (SGRP), 123,400 shares of Zevra Therapeutics, Inc. (ZVRA) and 18,549 shares of Newton Golf Company, Inc. (NWTG). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has John B Bode bought or sold stock recently?
The most recent open-market purchase was on August 19, 2025: bought 5,000 shares of Zevra Therapeutics, Inc. (ZVRA) for $45.8K at an average of $9.16.
How do I get alerts when John B Bode files?
Follow John B Bode on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. John B Bode filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by John B Bode (SEC CIK 0001612084). Totals count each trade once, skipping amendments whose original is on file, from May 9, 2023 on. View on SEC EDGAR